Currently browsing tag


Aly Song/Reuters

For Global Drug Manufacturers, China Becomes a Perilous Market

By Katie Thomas, NY Times Multinational drug companies now employ more sales agents in China than they do in the United States, their largest market. Several, including Merck and GlaxoSmithKline, are making huge scientific investments in the country, including building research and development centers. Within the next few years, China